DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Cellulitis and erysipelas

Essential points for quick revision.

!
Sepsis or deep destructive infection

Shock, rapidly progressive pain, bullae, skin anaesthesia, crepitus or pain out of proportion suggests sepsis or necrotising infection rather than routine cellulitis.

Action: Use ABCDE, mark the affected area, obtain urgent blood tests and cultures without delaying intravenous therapy, involve surgery immediately and escalate to critical care when physiology is unstable.

Synopsis

Recognise non-purulent bacterial skin infection, grade severity, distinguish common mimics and prescribe safe narrow therapy while addressing portals of entry and recurrence.

  • Cellulitis is a spreading infection of dermis and subcutaneous tissue; erysipelas is more superficial, raised and sharply demarcated.
  • Typical findings are unilateral warmth, erythema, tenderness and swelling, sometimes with lymphangitis or systemic upset.
  • Bilateral red legs are rarely bilateral cellulitis; venous stasis, lipodermatosclerosis and oedema are common mimics.

Key red flags

Pain out of proportion or rapidly advancing oedema suggests necrotising soft-tissue infection.

Systemic severity

Fever, rigors, tachycardia, hypotension, delirium or reduced urine output indicates systemic involvement and possible sepsis.

Investigation priorities

01
Clinical examination and marked marginFirst step

Define extent, severity, portal of entry and a reproducible baseline for reassessment.

Management branches

STABLEUse narrow oral treatment

Uncomplicated cellulitis is likely, physiology is stable and oral absorption and follow-up are reliable.

  1. Document the site, margin, pain, observations, portal of entry, allergy reaction, renal function and factors that alter organism risk.
  2. Give flucloxacillin 500 mg to 1 g orally four times daily for five to seven days when suitable, using a guideline-listed allergy alternative when needed.

Key medicines

FlucloxacillinGive 500 mg to 1 g orally four times daily for five to seven days for uncomplicated adult cellulitis; use intravenous dosing when severity requires admission.
ClarithromycinGive 500 mg orally twice daily for five to seven days when penicillin allergy makes flucloxacillin unsuitable.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom